Clonidine/levodopa/carbidopaLethary and drug inefficacy following off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71820-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：127 / 127

相关论文

共 50 条

[21] Dacarbazine/gemcitabineInefficacy following off-label treatment: case report
Reactions Weekly, 2021, 1872 (1) : 160 - 160
[22] TrametinibAcquired drug resistance with off-label treatment: case report
Reactions Weekly, 2019, 1774 (1) : 298 - 298
[23] DexamethasoneLack of efficacy following an off-label treatment: case report
Reactions Weekly, 2022, 1924 (1) : 189 - 189
[24] HydrocortisoneGastrointestinal mucormycosis following off-label treatment: case report
Reactions Weekly, 2022, 1911 (1) : 225 - 225
[25] TriamcinoloneOcular hypertension following off-label treatment: case report
Reactions Weekly, 2021, 1883 (1) : 351 - 351
[26] TocilizumabPulmonary infection following off-label treatment: case report
Reactions Weekly, 2020, 1799 (1) : 353 - 353
[27] ErtapenemAcquired drug resistance following off-label use: case report
Reactions Weekly, 2022, 1909 (1) : 245 - 245
[28] Carboplatin/gemcitabine/paclitaxelAllergic reaction and drug ineffective following off-label treatment: case report
Reactions Weekly, 2023, 1976 (1) : 98 - 98
[29] LinezolidAnaemia secondary to myelotoxicity following off-label treatment: case report
Reactions Weekly, 2019, 1763 (1) : 212 - 212
[30] DexamethasoneElizabethkingia meningoseptica sepsis following off-label treatment: case report
Reactions Weekly, 2021, 1862 (1) : 177 - 177

← 1 2 3 4 5 →